Integra LifeSciences Holdings Corporation
http://www.integralife.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Integra LifeSciences Holdings Corporation
Finance Watch: Amylyx, CinCor And Vigil Ready The First Biopharma IPOs Of 2022
Public Company Edition: Mergers with special purpose acquisition corporations also continue to take companies public, with three new SPAC offerings in late 2021. Also, Xeris raised $30m in a private placement of stock to support its recently approved drug and Sirnaomics went public in Hong Kong.
FDA Panel Recommends Against Approval Of Integra Mesh For Breast Reconstruction
The data supporting SurgiMend PRS ABDM isn’t enough to fully prove safety and effectiveness for that indication, the US FDA’s General and Plastic Surgery Devices Advisory Committee says.
Fracture Fixation Devices Market Projected A Return To Steady Growth
A new Informa Meddevicetracker report outlines projections for the fracture fixation devices market.
Breast Reconstruction Mesh, Endovascular Grafts In Focus At Fall FDA Meetings
Advisory committees within the US agency will hold an October session on a PMA for Integra’s SurgiMend PRS ABDM, as well as a two-day session on endovascular graft safety in November.
Company Information
- Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
- Other Names / Subsidiaries
-
- ACell, Inc.
- Arkis BioSciences
- Ascension Orthopedics
- Confluent Surgical, Inc.
- Derma Sciences, Inc.
- IsoTis Orthobiologics, Inc.
- Minnesota Scientific
- Newdeal SA
- Omni-Tract Surgical
- Innovative Spinal Technologies Inc.
- Rebound Therapeutics
- TEI Biosciences Inc.
- TEI Medical Inc.
- Terragraphix, Inc.
- TGX Medical
- TGX Medical Systems, LLC
- MCF I LP THX Medical System LLC Holdings, Inc.